Treatment-Related Morbidity in Prostate Cancer: A Comparison of 3-Dimensional Conformal Radiation Therapy With and Without Image Guidance Using Implanted Fiducial Markers-Reference-Cited by-同舟云学术

Treatment-Related Morbidity in Prostate Cancer: A Comparison of 3-Dimensional Conformal Radiation Therapy With and Without Image Guidance Using Implanted Fiducial Markers

Published:2013-03 Issue:4 Volume:85 Page:1018-1023
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Singh Jasmeet,Greer Peter B.,White Martin A.,Parker Joel,Patterson Jackie,Tang Colin I.,Capp Anne,Wratten Christopher,Denham James W.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Long term results of the M.D Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

2. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomized controlled trial;Dearnaley;Lancet Oncol,2007

3. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy;Peeters;J Clin Oncol,2006

4. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomised trial;Storey;Int J Radiat Oncol Biol Phys,2000

5. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer;Zelefsky;Eur Urol,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Dosimetric Comparison between Non-Image-Guided Radiation Therapy and Fiducial-Based Image-Guided Radiation Therapy with or without Reduced Margin in Intensity-Modulated Radiation Therapy for Prostate Cancer;Advances in Radiation Oncology;2024-08

2. Image guided radiotherapy in curative treatment for prostate cancer. 5-year results from a randomized controlled trial (RIC-trial);Radiotherapy and Oncology;2024-07

3. Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial;Journal of Radiation Research;2024-05

4. Intra-prostatic gold fiducial marker insertion for image-guided radiotherapy (IGRT): five-year experience on 795 patients;BMC Medical Imaging;2023-06-12

5. Effects of gold fiducial marker implantation on tumor control and toxicity in external beam radiotherapy of prostate cancer;Radiology and Oncology;2023-01-19